We are live on ! Find out more
AHPI

Allied Healthcare Products
AHPI

Delisted

AHPI was delisted on the 2nd of February, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in Allied Healthcare Products in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.12% less ownership

Funds ownership: 3.12% → 0% (-3.1%)

91% less funds holding

Funds holding: 11 → 1 (-10)

94% less capital inflows, than outflows

Capital inflows: $6.38K | Capital outflows: $109K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
1
Holders Change
-10
Holders Change %
-90.91%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$6.38K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$39K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$26.6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$20K
4
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors
New York
-$15.9K
5
UBS Group
UBS Group
Switzerland
-$6.87K

AHPI Hedge Fund Activity: Q1 2023 in Review

1 of the 6,289 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q1 2023, worth a combined $0 — down 100% from $114K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AHPI and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $6.38K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $39K sold.

  • 1 institutional investor held Allied Healthcare Products (AHPI) as of Q1 2023, down from 11 in Q4 2022.
  • Funds reported $0 of Allied Healthcare Products stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Allied Healthcare Products positions in Q1 2023 and 10 closed out, a net change of -10 holders.
  • The largest Allied Healthcare Products buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $6.38K added.
  • The largest Allied Healthcare Products seller in Q1 2023 was Renaissance Technologies, an estimated $39K sold.

Based on aggregated 13F filings for Q1 2023.